Načítá se...
The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases
Phosphodiesterase inhibitors (PDE) can be used as therapeutic agents for various diseases such as dementia, depression, schizophrenia and erectile dysfunction in men, as well as congestive heart failure, chronic obstructive pulmonary disease, rheumatoid arthritis, other inflammatory diseases, diabet...
Uloženo v:
| Vydáno v: | Glob Cardiol Sci Pract |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bloomsbury Qatar Foundation Journals
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4352681/ https://ncbi.nlm.nih.gov/pubmed/25780785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5339/gcsp.2014.42 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|